Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Sept. 06, 2025, 20:26 UTC
  • 8
  • 0 comments

Best Budget Student Laptops for Academic Success in 2025

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Sept. 06, 2025, 20:25 UTC
  • 7
  • 0 comments

Best Business Office Monitors for Professional Workspaces in 2025

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Sept. 06, 2025, 20:24 UTC
  • 5
  • 0 comments

Best Business Laptops for Professional Productivity in 2025

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Sept. 06, 2025, 20:24 UTC
  • 6
  • 0 comments

Best Closed Back Headphones for Audio Isolation and Quality (2025)

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Sept. 06, 2025, 20:16 UTC
  • 6
  • 0 comments

Under Desk Treadmills: Top Models and Buying Guide

Market reaction Comment Full text

Altimmune Inc (ALT)

  • Business News
  • Sept. 06, 2025, 19:06 UTC
  • 6
  • 0 comments

ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit

Market reaction Comment Full text

BridgeBio Pharma (BBIO)

  • Business News
  • Sept. 06, 2025, 18:30 UTC
  • 6
  • 0 comments

Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • Sept. 06, 2025, 07:01 UTC
  • 7
  • 0 comments

Johnson & Johnson - RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • Sept. 06, 2025, 07:00 UTC
  • 6
  • 0 comments

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer

Market reaction Comment Full text

Mettler-Toledo International Inc. (MTD)

  • Business News
  • Sept. 06, 2025, 03:50 UTC
  • 6
  • 0 comments

Garden Stage Limited - Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Market reaction Comment Full text

Unicycive Therapeutics Inc. (UNCY)

  • Business News
  • Sept. 06, 2025, 02:49 UTC
  • 9
  • 0 comments

UNCY Investors: If you Lost Significant Money in UNCY Contact Robbins LLP for Information About the Securities Fraud Class Action Against Unicycive Therapeutics, Inc.

Market reaction Comment Full text

Tharimmune Inc (THAR)

  • Technical Exchange News
  • Sept. 06, 2025, 01:57 UTC
  • 7
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Coherus BioSciences Inc (CHRS)

  • Technical Exchange News
  • Sept. 06, 2025, 01:57 UTC
  • 8
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Mettler-Toledo International Inc. (MTD)

  • Business News
  • Sept. 06, 2025, 01:48 UTC
  • 2
  • 0 comments

Colabor Group Inc. Announces Forbearance Agreements with Principal Lenders and Investissement Québec

Market reaction Comment Full text

Mettler-Toledo International Inc. (MTD)

  • Business News
  • Sept. 06, 2025, 01:48 UTC
  • 4
  • 0 comments

Groupe Colabor Inc. annonce des conventions de tolérance avec les prêteurs principaux et Investissement Québec

Market reaction Comment Full text
  • Previous
  • 102
  • 103
  • 104
  • 105
  • 106
  • Next

Search

News categories

  • Technical Exchange News(10033)
  • Event(412)
  • SEC News(169704)
  • FDA Approval(9405)
  • Company Report(721)
  • Business News(112992)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin